Twelve patients with levodopa‐induced dyskinesias were treated with continuous subcutaneous apomorphine. A markedly significant reduction in peak dose dyskinesias occurred over a two‐year follow‐up.
No takes yet. Share an insight, caveat, or question.
Kaňovský et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: